BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32367177)

  • 1. Uterine myeloid sarcoma.
    Martino G; Zanelli M; Zizzo M; Quintini M; Ricci L; Marra A; Ascani S
    Ann Hematol; 2020 Jul; 99(7):1671-1672. PubMed ID: 32367177
    [No Abstract]   [Full Text] [Related]  

  • 2. Proximal-type epithelioid sarcoma of the uterine corpus.
    Venizelos I; Anagnostou E; Papathomas TG; Arsos G; Mentzel T
    Histopathology; 2011 Jan; 58(2):321-3. PubMed ID: 21255067
    [No Abstract]   [Full Text] [Related]  

  • 3. Skin nodules in onset of acute myeloid leukemia, a myelomonocytic variant case.
    Bertolini F; Cassisa A; Miggiano MC; Gasparin P
    G Ital Dermatol Venereol; 2017 Dec; 152(6):686-688. PubMed ID: 29050457
    [No Abstract]   [Full Text] [Related]  

  • 4. Aggressive endometrial stromal sarcoma responding to medroxyprogesterone following failure of tamoxifen and combination chemotherapy. Case report.
    O'Brien AA; O'Briain DS; Daly PA
    Br J Obstet Gynaecol; 1985 Aug; 92(8):862-6. PubMed ID: 4027213
    [No Abstract]   [Full Text] [Related]  

  • 5. Granulocytic sarcoma with massive scalp involvement.
    Quintás-Cardama A; Harb AJ; Amin HM; Verstovsek S
    Am J Hematol; 2008 Apr; 83(4):340-2. PubMed ID: 17685484
    [No Abstract]   [Full Text] [Related]  

  • 6. Uterine sarcoma: steroid receptors and response to hormonal therapy.
    Wade K; Quinn MA; Hammond I; Williams K; Cauchi M
    Gynecol Oncol; 1990 Dec; 39(3):364-7. PubMed ID: 2258084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia presenting as granulocytic sarcoma of the lung.
    Wong KF; Chan JK; Chan JC; Lam SY
    Am J Hematol; 1993 May; 43(1):77-8. PubMed ID: 8317473
    [No Abstract]   [Full Text] [Related]  

  • 8. Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML).
    Zeidner JF; Foster MC; Blackford AL; Litzow MR; Morris LE; Strickland SA; Lancet JE; Bose P; Levy MY; Tibes R; Gojo I; Gocke CD; Rosner GL; Little RF; Wright JJ; Doyle LA; Smith BD; Karp JE
    Leuk Res; 2018 Sep; 72():92-95. PubMed ID: 30118897
    [No Abstract]   [Full Text] [Related]  

  • 9. Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: long-term results of a single institution experience.
    Papadimitriou CA; Zorzou MP; Markaki S; Rodolakis A; Voulgaris Z; Bozas G; Kastritis E; Bamias A; Gika D; Dimopoulos MA
    Eur J Gynaecol Oncol; 2007; 28(2):109-16. PubMed ID: 17479671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dissociation between the effect on myeloblastoma and the hematologic effect of Ara-C therapy: report of an autopsied myeloblastic leukemia case with around five-year course].
    Koyama T; Tohda S; Kamiyama T; Suzuki T; Nagata K; Nakamura Y; Miura O; Maruyama Y; Kato A; Murakami N
    Rinsho Ketsueki; 1988 Dec; 29(12):2302-6. PubMed ID: 3246715
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolated granulocytic sarcoma of the orbit.
    Kumar J; Seith A; Bakhshi S; Kumar R; Kumar A; Sen S
    Eur J Haematol; 2007 May; 78(5):456. PubMed ID: 17391338
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of combined chemotherapy for the treatment of advanced sarcoma of the uterus.
    Psikakos G; Papanicolaou A; Boutis L; Goutzioulis M; Makedos G; Papanicolaou N
    Eur J Gynaecol Oncol; 1996; 17(4):289-91. PubMed ID: 8856308
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraperitoneal and systemic chemotherapy for advanced endometrial adenocarcinoma: a case report.
    Vaughn CB; Chapman JL; Herschman BR; Bonczak MJ; Treisman EJ; Groshko GA; Nirenberg PL
    Med Pediatr Oncol; 1990; 18(1):68-71. PubMed ID: 2294393
    [No Abstract]   [Full Text] [Related]  

  • 14. Granulocytic sarcoma of the gingiva with trisomy 21.
    Yinjun L; Jie J; Zhimei C
    Am J Hematol; 2006 Jan; 81(1):79-80. PubMed ID: 16369955
    [No Abstract]   [Full Text] [Related]  

  • 15. Population Pharmacokinetics and Exposure-Response Analyses for CPX-351 in Patients With Hematologic Malignancies.
    Wang Q; Banerjee K; Vasilinin G; Marier JF; Gibbons JA
    J Clin Pharmacol; 2019 May; 59(5):748-762. PubMed ID: 30566230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid receptors in endolymphatic stromal myosis.
    Baker VV; Walton LA; Fowler WC; Currie JL
    Obstet Gynecol; 1984 Mar; 63(3 Suppl):72S-74S. PubMed ID: 6700885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensifying induction therapy in acute myeloid leukemia by an infusional chemotherapy schedule.
    Friedenberg WR
    Cancer Invest; 1998; 16(7):542-3. PubMed ID: 9774962
    [No Abstract]   [Full Text] [Related]  

  • 18. Daunorubicin and Cytarabine Liposome in Newly Diagnosed Therapy-Related Acute Myeloid Leukemia (AML) or AML With Myelodysplasia-Related Changes.
    Kim M; Williams S
    Ann Pharmacother; 2018 Aug; 52(8):792-800. PubMed ID: 29532662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell lines.
    Coley HM; Shotton CF; Kokkinos MI; Thomas H
    Gynecol Oncol; 2007 May; 105(2):462-9. PubMed ID: 17300833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unforeseen Severe Cardiotoxicity Associated With Daunorubicin Chemotherapy Even at a Dose Previously Thought to Be Safe: A Case Report.
    Juan MCY; Jones RT; Thabolingam RC
    Am J Ther; 2017; 24(4):e503-e504. PubMed ID: 27272204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.